Umoja Biopharma

IASO Biotechnology, a China-based company, and Umoja Biopharma, a California-headquartered developer of off-the-shelf cell therapies, have announced a collaboration agreement to research, develop, and commercialize innovative in vitro and in vivo cell and gene therapies (CGTs). This collaboration expands on a previous agreement in November 2022, where the two companies…